Continued circulation, recombination and evolution of the ancient subcontinent lineage despite predominance of the recent arctic-like lineage rabies viruses (RABV) in India

Kuchipudi, S. V.; Deventhiran, J.; Srinivasan, B.; Seeralan, M.; Kanagaraj, V.; Raju, S.; Kathaperumal, K.; Nissly, R. H.; Kasibhatla, S. M.; Kale, M. M.; Kulkarni-Kale, U.

doi:10.1101/398180

bioRxiv · 10.1101/398180

Continued circulation, recombination and evolution of the ancient subcontinent lineage despite predominance of the recent arctic-like lineage rabies viruses (RABV) in India

Kuchipudi, S. V.·Deventhiran, J.·Srinivasan, B.·Seeralan, M.·Kanagaraj, V.·Raju, S.·Kathaperumal, K.·Nissly, R. H.·Kasibhatla, S. M.·Kale, M. M.·Kulkarni-Kale, U.

View original source ↗Export metadata ↓

Abstract

BackgroundRabies is an emerging and re-emerging lethal encephalitis causing 26,400 to 61,000 human deaths annually. Approximately 20,000 people die of rabies every year in India that accounts to 36% of the worlds rabies deaths. Rabies is endemic among domestic dogs in India and there are conflicting reports on the currently circulating RABV lineages in domestic dogs in India. Further, movement of humans and animals between Sri Lanka and southern coastal states of India was proposed to be a source of the emergence of variant RABV in India. For effective prevention and control of rabies in India it is essential to establish the genetic diversity and evolutionary dynamics of RBAV currently circulating in India.\n\nMethodsWe carried out molecular evolution and recombination analyses of nucleoprotein (N) and glycoprotein (G) genes of 26 RABV isolates from southern Indian states of Tamil Nadu and Goa.\n\nResultsWe found continued co-circulation of ancient subcontinent lineage despite predominance of the recent arctic-like lineage RABVs in southern India. The mean rate of nucleotide substitution in G and N genes was 1.32 x 10-3 and 1.91 x 10-4 substitutions/site/yr respectively. The study also found recombination in both N and G genes and a higher mean rate of evolutionary changes in G gene among Indian dog RABV isolates than those of lyssaviruses. The Indian subcontinent lineage RABV isolates investigated in this study clustered closely with other subcontinent lineage viruses from Sri Lanka highlighting the continued incursion and/or circulation of the variant subcontinent lineages of RABVs between India and Sri Lanka.\n\nConclusionWe report that there is enzootic viral establishment of two distinct RABV lineages in domestic dogs in India that are evolving at a greater rate.\n\nAuthor summaryRabies is a fatal viral disease that has no treatment and can only be prevented by post-exposure vaccination. In many parts of Asia and Africa, rabies continues to be a major public health threat almost always caused by dog bites. In this study, we investigated the genetic diversity and rate of evolution among rabies viruses isolated from dogs in India. We found that two distinct lineages of Rabies viruses (RABVs) namely the ancient subcontinent lineage and a more recent arctic-like lineage co-circulate among dogs in India. Notably, our study found that the dog rabies viruses in India are undergoing recombination and evolving at a higher rate than other lyssaviruses. Phylogenetic analysis revealed continued incursion and/or circulation of the variant subcontinent lineages of RABVs in India that might have been originated from Sri Lanka. Our study indicates that two distinct lineages of RABVs are maintained and currently circulate among dog population in India

Explore related subjects

microbiology Preprint

Keep this discovery

BibTeX RIS

Kuchipudi, S. V., Deventhiran, J., Srinivasan, B., Seeralan, M., Kanagaraj, V., Raju, S., Kathaperumal, K., Nissly, R. H., Kasibhatla, S. M., Kale, M. M., Kulkarni-Kale, U.. 2018-08-22. Continued circulation, recombination and evolution of the ancient subcontinent lineage despite predominance of the recent arctic-like lineage rabies viruses (RABV) in India. https://doi.org/10.1101/398180

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

bioRxiv2026

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

bioRxiv2026

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗